Home ETF List About

Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for AMPH

Stock NameAmphastar P
TickerAMPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03209R1032
LEI54930055TH0ZLSAQMJ38

Show aggregate AMPH holdings

News associated with AMPH

Amphastar Pharmaceuticals (NASDAQ:AMPH) Given New $32.00 Price Target at Bank of America
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its target price upped by Bank of America from $28.00 to $32.00 in a research report report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock. Several other research firms also recently weighed in on AMPH. JPMorgan Chase & Co. reissued a “neutral” rating […] - 2025-08-27 02:52:54
Amphastar Pharmaceuticals (NASDAQ:AMPH) vs. Personalis (NASDAQ:PSNL) Financial Contrast
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and Personalis (NASDAQ:PSNL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Amphastar Pharmaceuticals has a beta […] - 2025-08-20 02:55:13
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $25.00
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target trimmed by Piper Sandler from $30.00 to $25.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a “hold” rating on shares […] - 2025-08-11 03:08:44
The Math Shows IJS Can Go To $119
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:57:20
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Raised by Victory Capital Management Inc.
Victory Capital Management Inc. grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 27.9% in the first quarter, Holdings Channel.com reports. The fund owned 81,087 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,351,000 […] - 2025-07-29 04:20:54
New York State Common Retirement Fund Acquires 11,075 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
New York State Common Retirement Fund lifted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 15.7% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 81,565 shares of the company’s stock after purchasing an additional 11,075 shares during the quarter. New York State Common Retirement Fund’s holdings in Amphastar Pharmaceuticals were […] - 2025-07-24 04:40:46
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 493,214 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 85.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,231 shares of the company’s […] - 2025-06-06 04:42:49
Squarepoint Ops LLC Buys 11,929 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Squarepoint Ops LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 208.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,664 shares of the company’s stock after purchasing an additional 11,929 shares during the period. Squarepoint Ops […] - 2025-06-03 05:38:56
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Nuveen Asset Management LLC trimmed its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 54.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 95,665 shares of the company’s stock after selling 112,307 shares during the quarter. Nuveen Asset Management LLC’s holdings […] - 2025-06-02 05:04:53
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Two Sigma Investments LP
Two Sigma Investments LP lowered its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 98,184 shares of the company’s stock after selling 614 shares during the quarter. Two Sigma Investments LP’s holdings in Amphastar Pharmaceuticals were worth $3,646,000 as of […] - 2025-05-29 05:14:54
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Two Sigma Advisers LP lessened its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 12.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,900 shares of the company’s stock after selling 12,400 shares during the period. Two Sigma Advisers LP’s holdings in Amphastar Pharmaceuticals were worth $3,189,000 as of its most […] - 2025-05-27 05:57:02
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 21,257 shares of the company’s stock after selling 610 shares during the period. The Manufacturers Life Insurance Company’s holdings in Amphastar Pharmaceuticals were worth $789,000 as […] - 2025-05-15 04:45:07
Northern Trust Corp Purchases 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Northern Trust Corp raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 5.1% in the fourth quarter, HoldingsChannel reports. The firm owned 613,170 shares of the company’s stock after acquiring an additional 29,808 shares during the period. Northern Trust Corp’s holdings in Amphastar Pharmaceuticals were worth $22,767,000 as of its […] - 2025-05-13 05:28:51
Hsbc Holdings PLC Boosts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Hsbc Holdings PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,991 shares of the company’s stock after purchasing an additional 1,707 shares during the quarter. […] - 2025-05-09 05:41:01
Analysts Forecast 23% Gains Ahead For IJT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:57:34
First Trust Advisors LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
First Trust Advisors LP boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 350.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,129 shares of the company’s stock after purchasing an additional 63,100 shares during the quarter. […] - 2025-05-04 05:30:50
Barclays PLC Acquires 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Barclays PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,790 shares of the company’s stock after acquiring an additional 10,334 shares during the period. Barclays PLC’s holdings […] - 2025-04-30 05:12:50
Raymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company’s stock, valued at approximately $3,450,000. Raymond James Financial Inc. owned approximately 0.19% of Amphastar […] - 2025-04-28 05:06:47
Vanguard Group Inc. Has $100.79 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Vanguard Group Inc. increased its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,714,628 shares of the company’s stock after acquiring an additional 3,155 shares during the quarter. Vanguard Group Inc. owned 0.06% of Amphastar Pharmaceuticals worth $100,794,000 as of […] - 2025-04-10 04:38:49
American Century Companies Inc. Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
American Century Companies Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 26.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 472,017 shares of the company’s stock after selling 167,575 shares during the period. American Century Companies Inc.’s holdings in Amphastar Pharmaceuticals were worth $17,526,000 at the […] - 2025-04-01 05:38:53
Thrivent Financial for Lutherans Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,988 shares of the company’s stock after selling 827 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amphastar Pharmaceuticals were worth $1,076,000 at […] - 2025-04-01 04:40:47
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Victory Capital Management Inc. cut its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 71.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,387 shares of the company’s stock after selling 155,144 shares during the period. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,354,000 as of […] - 2025-03-18 05:41:08
AlphaQuest LLC Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,862 shares of the company’s stock after selling 2,724 shares during the period. AlphaQuest […] - 2025-03-17 06:03:06
Smartleaf Asset Management LLC Buys 493 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 715 shares of the company’s stock after purchasing an additional 493 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Amphastar Pharmaceuticals were worth $26,000 […] - 2025-03-13 05:54:49
Assetmark Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Assetmark Inc. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,921 shares of the company’s stock after selling 1,985 shares during the period. Assetmark Inc.’s holdings in Amphastar Pharmaceuticals were […] - 2025-03-11 06:20:51
Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Neutral” Rating by Piper Sandler
Piper Sandler cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $36.00 price target on the stock, down from their previous price target of $66.00. A number of other equities research analysts also […] - 2025-02-05 06:38:50

iShares MSCI World Small Cap UCITS ETF USD (Acc) AMPH holdings

DateNumber of AMPH Shares HeldBase Market Value of AMPH SharesLocal Market Value of AMPH SharesChange in AMPH Shares HeldChange in AMPH Base ValueCurrent Price per AMPH Share HeldPrevious Price per AMPH Share Held
2025-10-15 (Wednesday)29,797USD 689,503USD 689,503
2025-10-10 (Friday)29,608USD 699,637USD 699,637
2025-10-08 (Wednesday)29,608USD 769,216USD 769,216
2025-10-07 (Tuesday)29,608AMPH holding increased by 126USD 764,775AMPH holding decreased by -18857USD 764,775126USD -18,857 USD 25.83 USD 26.58
2025-10-06 (Monday)29,482USD 783,632AMPH holding decreased by -5012USD 783,6320USD -5,012 USD 26.58 USD 26.75
2025-10-03 (Friday)29,482USD 788,644AMPH holding increased by 6781USD 788,6440USD 6,781 USD 26.75 USD 26.52
2025-10-02 (Thursday)29,482USD 781,863AMPH holding decreased by -13856USD 781,8630USD -13,856 USD 26.52 USD 26.99
2025-10-01 (Wednesday)29,482USD 795,719AMPH holding increased by 10024USD 795,7190USD 10,024 USD 26.99 USD 26.65
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AMPH by Blackrock for IE00BF4RFH31

Show aggregate share trades of AMPH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-07BUY126 25.830* 32.29
2025-09-08SELL-248 29.260* 32.55 Profit of 8,072 on sale
2025-08-15BUY122 29.830* 32.56
2025-08-07BUY372 21.620* 32.63
2025-07-29BUY124 21.670* 33.02
2025-07-14BUY252 21.950* 33.49
2025-06-30BUY252 22.960* 33.95
2025-06-25BUY372 23.450* 34.16
2025-06-20SELL-63 24.560* 34.34 Profit of 2,163 on sale
2025-06-12SELL-504 26.440* 34.68 Profit of 17,480 on sale
2025-06-02BUY189 25.380* 35.17
2025-05-28BUY126 25.260* 35.38
2025-05-14BUY63 23.300* 36.22
2025-05-13BUY126 23.880* 36.32
2025-05-07BUY189 24.430* 36.70
2025-04-28BUY63 24.410* 37.44
2025-04-16BUY819 22.990* 38.45
2025-04-14BUY126 24.420* 38.72
2025-04-08SELL-124 23.750* 39.29 Profit of 4,872 on sale
2025-04-04SELL-126 26.610* 39.56 Profit of 4,984 on sale
2025-03-28BUY630 28.430* 40.02
2025-03-12SELL-126 26.280* 41.76 Profit of 5,262 on sale
2025-03-04SELL-126 27.620* 42.62 Profit of 5,370 on sale
2025-02-26SELL-248 31.210* 43.30 Profit of 10,738 on sale
2025-02-13BUY63 31.740* 44.90
2025-02-12BUY252 31.820* 45.09
2025-01-27BUY62 37.110* 47.51
2025-01-23BUY62 36.390* 47.93
2024-12-09BUY2,232 43.830* 48.35
2024-12-04BUY122 44.300* 48.64
2024-12-03BUY183 44.920* 48.72
2024-11-19BUY372 43.620* 50.00
2024-11-18BUY124 44.160* 50.18
2024-11-12BUY244 47.710* 50.25
2024-11-11BUY61 48.570* 50.37
2024-11-11BUY61 48.570* 50.37
2024-11-07BUY300 46.090* 50.85
2024-11-07BUY300 46.090* 50.85
2024-10-23BUY120 49.830* 50.60
2024-10-23BUY120 49.830* 50.60
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AMPH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1955,7460114,92048.5%
2025-09-1889,1750173,57151.4%
2025-09-17443,2390520,39685.2%
2025-09-16111,9160181,52361.7%
2025-09-1573,0070149,65948.8%
2025-09-1243,242096,38444.9%
2025-09-1154,5986115,30547.4%
2025-09-1052,436097,93653.5%
2025-09-0977,3480171,12845.2%
2025-09-0872,8770141,50951.5%
2025-09-0591,062191167,75754.3%
2025-09-04157,7220260,18960.6%
2025-09-0381,10870186,89643.4%
2025-09-02100,2460148,26767.6%
2025-08-2962,5880116,35653.8%
2025-08-2837,1620118,42331.4%
2025-08-2754,0390103,85952.0%
2025-08-2656,8170129,49243.9%
2025-08-2546,8980143,08232.8%
2025-08-2264,0100166,91638.3%
2025-08-2169,7450185,49137.6%
2025-08-2063,19669138,13145.8%
2025-08-19122,54733187,47765.4%
2025-08-1870,958250167,86942.3%
2025-08-15166,0260240,16069.1%
2025-08-1499,05917175,55456.4%
2025-08-13218,96929,560374,49158.5%
2025-08-12405,1060607,75166.7%
2025-08-11340,1394,251644,08052.8%
2025-08-08168,545281406,78741.4%
2025-08-07168,5310307,60454.8%
2025-08-0678,93521144,12754.8%
2025-08-0547,0660138,56934.0%
2025-08-0467,6800152,92444.3%
2025-08-0191,4140174,78952.3%
2025-07-31109,0030200,47254.4%
2025-07-3045,1890124,57936.3%
2025-07-2984,9951,699128,55766.1%
2025-07-28101,4360189,51753.5%
2025-07-2534,1290120,02428.4%
2025-07-2432,423097,43433.3%
2025-07-23102,1100207,04649.3%
2025-07-2273,751567161,84245.6%
2025-07-2189,9920161,38755.8%
2025-07-1870,0010152,26246.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.